PLAU and cancer: In patients with cancer, TNFα was capable of eliciting the release of a tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), and PAI-1 into circulation, indicative of the activation and rapid inactivation of fibrinolysis [18].